 |
인쇄하기
취소
|
Sandoz looking at Korean OTC market.
Sandoz, a subsidiary of Novartis's OTC business, is now seeking for the OTC drug market in Korea.
Novartis Korea said that Sandoz, a Novartis affiliate for the OTC drug business, took over Hexal AG, the 2nd top OTC drug maker in Germany, early this year, would soon enter the Korean market for the OTC drug business.
Hexal AG recorded 1,700 billion won of sales in2003 and its merger lifted Sa...
Novartis Korea said that Sandoz, a Novartis affiliate for the OTC drug business, took over Hexal AG, the 2nd top OTC drug maker in Germany, early this year, would soon enter the Korean market for the OTC drug business.
Hexal AG recorded 1,700 billion won of sales in2003 and its merger lifted Sa...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.